BIOMAT Database Logo BIOMAT Database Logo

New Diagnostic Possibilities for Neonatal Sepsis. 2018

Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
Neonatology and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico "San Matteo," Pavia, Italy.

Progress in neonatal care has decrease morbidity and mortality due to neonatal sepsis (NS). Although diagnosis of sepsis continues to rely on blood culture, this method is too slow and limited by false-negative results. There are numerous sepsis biomarkers that have been evaluated for the early diagnosis of NS, but, to date, there is no single ideal biomarker, though novel biomarkers are becoming more sophisticated and specific in their clinical applications. This review provides an overview of the current diagnostic approaches available or under development for diagnosing NS.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071074 Neonatal Sepsis Blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life and most often appears within 24 hours of birth. Late-onset occurs after 1 week and before 3 months of age. Neonatal Early-Onset Sepsis,Neonatal Late-Onset Sepsis,Sepsis, Neonatal,Early-Onset Sepses, Neonatal,Early-Onset Sepsis, Neonatal,Late-Onset Sepses, Neonatal,Late-Onset Sepsis, Neonatal,Neonatal Early Onset Sepsis,Neonatal Early-Onset Sepses,Neonatal Late Onset Sepsis,Neonatal Late-Onset Sepses,Neonatal Sepses,Sepses, Neonatal,Sepses, Neonatal Early-Onset,Sepses, Neonatal Late-Onset,Sepsis, Neonatal Early-Onset,Sepsis, Neonatal Late-Onset
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D017452 Receptors, IgG Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor). Antigens, CD16,Antigens, CD32,Antigens, CD64,CD16 Antigens,CD32 Antigens,CD64 Antigen,CD64 Antigens,Fc Gamma Receptor,Fc Receptors, gamma,Fc gamma Receptors,IgG Receptor,IgG Receptors,Leu-11 Antigen,Receptors, Fc gamma,gamma Fc Receptor,gamma Fc Receptors,CD 16 Antigens,CD 32 Antigens,CD 64 Antigens,CDw32 Antigens,Fc gamma RI,Fc gamma RII,Fc gamma RIII,Immunoglobulin G Receptor,Leu-11 Antigens,Antigen, CD64,Antigen, Leu-11,Antigens, CD 16,Antigens, CD 32,Antigens, CD 64,Antigens, CDw32,Antigens, Leu-11,Fc Receptor, gamma,Gamma Receptor, Fc,Leu 11 Antigen,Leu 11 Antigens,Receptor, Fc Gamma,Receptor, IgG,Receptor, Immunoglobulin G,Receptor, gamma Fc,Receptors, gamma Fc,gamma RI, Fc,gamma RII, Fc,gamma RIII, Fc,gamma Receptors, Fc
D042241 Early Diagnosis Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME. Early Detection of Disease,Diagnosis, Early,Disease Early Detection
D018950 Lipopolysaccharide Receptors Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein. Antigens, CD14,CD14 Antigens,Receptors, Lipopolysaccharide,Soluble CD14,Soluble CD14 Antigen,Soluble CD14 Protein,sCD14,CD14 Antigen,CD14 Monocyte Differentiation Antigen,LPS Receptor,Lipoglycan Receptor,Receptor, LPS,Receptor, Lipoglycan,CD14 Antigen, Soluble,CD14 Protein, Soluble,CD14, Soluble

Related Publications

Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
[New diagnostic and therapeutic possibilities in neonatal sepsis].
November 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
New Diagnostic Possibilities for Early Onset Neonatal Sepsis: Red Cell Distribution Width to Platelet Ratio.
August 2020, Fetal and pediatric pathology,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
The search for new diagnostic tests for neonatal sepsis.
November 2009, The Journal of pediatrics,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
New diagnostic possibilities in systemic neonatal infections: metabolomics.
March 2014, Early human development,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
Diagnostic markers for neonatal sepsis.
April 2006, Current opinion in pediatrics,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
[New diagnostic possibilities].
January 1996, Annales d'urologie,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
Diagnostic tests in neonatal sepsis.
June 2008, Current opinion in infectious diseases,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
[Diagnostic advances in neonatal sepsis].
October 1984, Anales espanoles de pediatria,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
Point of Care Diagnostic Markers for Neonatal Sepsis.
January 2024, Indian journal of pediatrics,
Chryssoula Tzialla, and Paolo Manzoni, and Cristian Achille, and Lina Bollani, and Mauro Stronati, and Alessandro Borghesi
[Neonatal sepsis: bases and possibilities for immunotherapy and immunoprophylaxis. 2: Immunotherapy].
January 1990, Padiatrie und Grenzgebiete,
Copied contents to your clipboard!